Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

23.0K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
23.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A serologic weak D expressed by a combined weak D type 1/41.0.1 allele.

Transfusion·2026
Same author

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Gothenburg, Barcelona and four virtual business meetings: Update on blood group systems.

Vox sanguinis·2025
Same author

Kell and Kx blood group systems: an update.

Immunohematology·2025
Same author

JK*01(307C) encodes a JK null allele.

Transfusion·2025
Same author

Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.

Obstetrics and gynecology·2024
Same author

Defining the breakpoints of hybrid blood group alleles.

Blood transfusion = Trasfusione del sangue·2024

Related Experiment Video

Updated: Mar 31, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Mass-scale donor red cell genotyping using real-time array technology.

Gregory A Denomme1, Michael J Schanen2

  • 1PhD, FCSMLS(D) (corresponding author), Director, Immunohematology and Transfusion Services, Diagnostic Laboratories, Blood Center of Wisconsin, and Senior Investigator, Blood Research Institute.

Immunohematology
|October 27, 2015
PubMed
Summary

Mass-scale red cell genotyping of blood donors can identify rare blood types and antigen combinations. This method, using TaqMan chemistry, provides real-time data for blood centers to meet transfusion demands.

More Related Videos

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping
07:00

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

18.0K
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K

Related Experiment Videos

Last Updated: Mar 31, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K
qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping
07:00

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

18.0K
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K

Area of Science:

  • Transfusion Medicine
  • Genetics
  • Immunology

Background:

  • Blood centers can screen numerous donations for antigen-negative blood types.
  • Traditional hemagglutination methods have limitations.
  • Red cell genotyping offers a solution to overcome these limitations.

Purpose of the Study:

  • To review a methodology for mass-scale red cell genotyping of blood donors.
  • To highlight the benefits of integrating genotype data with donor information.
  • To identify rare blood phenotypes and antigen combinations.

Main Methods:

  • Utilizing red cell genotyping with synthesized reagents targeting blood group antigen single nucleotide polymorphisms.
  • Employing TaqMan chemistry for genotyping.
  • Integrating genotype data with existing donor data and demographics.

Main Results:

  • Genotyping circumvents limitations of hemagglutination.
  • Mass-scale genotyping can identify rare blood phenotypes and antigen combinations.
  • Integrated data provides real-time information on clinically relevant blood group antigens.

Conclusions:

  • Mass-scale red cell genotyping is a valuable tool for blood centers.
  • This methodology enhances the ability to identify and supply needed blood types.
  • Optimizing donor data through genotyping improves transfusion service support.